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doi:10.1016/j.jtcvs.2004.02.018402 The Journal of Thoracic and CardioObjective: We sought to assess the long-term outcome of Heller myotomy and
anterior fundoplication in patients with achalasic sigmoid esophagus.
Methods: Fourteen patients with achalasia and sigmoid esophagus (median age, 42.5
years) operated on by the same surgeon through a laparotomy (n  8) or laparo-
scopic approach (n  6) between 1985 and 2000 were evaluated. According to a
4-grade classification (1, no symptoms; 4, persistent symptoms), both dysphagia and
regurgitation had a median score of 4.0. Five patients complained of respiratory
symptoms. Six patients had undergone previous pneumatic dilation. Preoperative
and postoperative workup included an esophagogram, esophagoscopy, manometry,
and health-related quality-of-life assessment with the Short-Form 36-item question-
naire.
Results: Median follow-up was 85 months. At 24 months, esophageal width de-
creased by 10 mm (P  .003), and the change correlated inversely with the age of
the patients (R  0.61; P  .02). Lower esophageal sphincter pressure decreased
by 17 mm Hg (P  .001), and both dysphagia and regurgitation scores decreased to
1.0 (P  .003). Comparison with the results of 37 patients with earlier-stage
achalasia showed no difference in changes of esophageal width, lower esophageal
sphincter pressure, dysphagia score, and regurgitation score. Quality-of-life Short-
Form 36-item questionnaire domains, including general health, social functioning,
and vitality, improved significantly. Overall results were classified as excellent or
good in 10 patients and as satisfactory and unsatisfactory in 2 patients each. No
patient required esophagectomy or had esophageal carcinoma.
Conclusion: In this study Heller myotomy proved effective in improving subjective,
objective, and quality-of-life outcome measures in patients with achalasic sigmoid
esophagus and should be considered as the first-choice treatment for this severe
condition.
Achalasia is an idiopathic motility disorder of the esophagus char-acterized by a lack of peristalsis in the esophageal body andabsent or incomplete relaxation of the lower esophageal sphincter.Because there is no curative therapy for achalasia, both surgicaland nonsurgical palliative treatment modalities have been devel-oped with the aim of decreasing the lower esophageal sphincter
pressure (LESP), thus facilitating esophageal emptying.1
Heller myotomy with anterior fundoplication performed by using either laparot-
omy or laparoscopic approaches2,3 represents a reliable and effective surgical
treatment for achalasia, with good to excellent palliation of dysphagia in more than
80% of patients4-7 and significant improvements in health-related quality of life
(QOL).8-12 Nonetheless, the optimal treatment of patients with achalasic sigmoid
esophagus, which is thought to represent the most advanced stage of disease,
remains controversial. Some surgeons recommend myotomy as the initial treatment
13and reserve esophageal resection for patients with persistent symptoms ; others
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believing that marked esophageal dilation and redundancy
predict the impossibility of improving emptying by means
of simple myotomy.14-16 For this reason, it is desirable to
perform a comprehensive assessment of the results, includ-
ing subjective, objective, and QOL measures, to help iden-
tify the most effective therapy for this patient subgroup.
The aim of this study was to analyze the long-term
outcome of Heller myotomy and anterior fundoplication
performed by the same surgeon as the first-choice surgical
treatment in patients with achalasic sigmoid esophagus.
Material and Methods
Between 1985 and 2000, 51 patients with esophageal achalasia
underwent Heller myotomy and anterior Dor fundoplication per-
formed by the same surgeon (T.C.M.) at our institution. Among
these, 14 patients with sigmoid esophagus were evaluated in a
retrospective case-control study in which the patient cohort with
earlier-stage achalasia (37 patients) was taken as a control group.
In all instances, an identical surgical technique2 was performed
through laparotomy (8 patients) or, more recently, through a lapa-
roscopic approach (6 patients). The diagnosis was made on the
basis of clinical history, esophagograms, endoscopy, and manom-
etry. All patients had disabling dysphagia and regurgitation. Me-
dian duration of symptoms was 38.5 months. Six patients had
undergone a previous pneumatic dilation.
The stage of the disease was established by evaluating the
degree of esophageal body dilation expressed in centimeters by
measuring the maximum esophageal width from standard pos-
teroanterior projection esophagograms. As a result, achalasia was
classified in 4 stages: stage I, esophageal width of 4 cm or less;
stage II, width of between 4 and 6 cm; stage III, width of greater
than 6 cm; stage IV, width of greater than 6 cm and sigmoid-
shaped esophagus.
Dysphagia, regurgitation, chest pain, and heartburn were clas-
sified preoperatively and postoperatively into 4 grades: grade 1, no
symptoms; grade 2, mild symptoms occurring less than once
TABLE 1. Preoperative characteristics of the study group
achalasia
Sigmoid esophagus group (n
Age (y) 42.5 35-
Sex (male/female) 8/6 —
Symptom duration (mo) 38 30-
Esophageal width (cm) 7.0 6.5-
LESP (mm Hg) 39 29-
Dysphagia score (1-4) 4.0 4.0-
Regurgitation score (1-4) 4.0 4.0-
Chest pain score (1-4) 1.0 1.0-
Heartburn (1-4) 1.0 1.0-
Respiratory symptoms (N) 5 —
Weight loss (kg) 0 0-
Averaged data are expressed as medians with interquartile ranges.
NS, Not significant; LESP, lower esophageal sphincter pressure.weekly; grade 3, moderate symptoms occurring more than once
The Journal of Thoraciweekly but not every day; and grade 4, severe and persistent
symptoms. In addition, since 1995, QOL was assessed preopera-
tively and postoperatively in all patients by means of the Short-
Form 36-item (SF-36) questionnaire in the version validated in
Italy.17
Finally, the overall result was scored as excellent if the patient
had no symptoms, good if the patient had not more than one
symptom with a score of 2, satisfactory if the patient’s dysphagia
score improved by at least one grade and there was a maximum of
one other symptom with a score of greater than 2, and unsatisfac-
tory if the postoperative dysphagia score did not improve or the
patient had any other symptom with a score of 4.
Descriptive statistics are presented as medians with interquar-
tile ranges. Because of the small sample size and the not normal
distribution of data, comparison of paired and unpaired data was
performed by using the Wilcoxon rank sum test and the Mann-
Whitney test, respectively. The relationship between variables was
assessed by using the Spearman correlation coefficients. Statistical
analysis was carried out with Statistica software (StatSoft, Inc,
Tulsa, Okla).
Results
Demographics and baseline data are detailed in Table 1. In
the control group achalasia was classified as stage 1, 2, and
3 in 16, 18, and 3 patients, respectively. In the sigmoid
group 6 patients had lost some weight before the operation.
Eleven patients complained of grade 4 dysphagia, and all
had grade 4 regurgitation. Yet 5 patients had respiratory
symptoms, including recurrent pneumonia in 4 patients and
asthma attacks in 1 patient. Chest pain and heartburn were
less frequent preoperative findings, occurring in 2 patients
and 1 patient, respectively. Comparison with the control
group data demonstrated that apart from the obvious greater
esophageal width, patients with sigmoid esophagus had a
significantly longer duration of symptoms, a greater inci-
dence of respiratory complaints, and a higher regurgitation
pared with those of a control group with earlier-stage
) Control group (n  37)
Intergroup
P value
40 33.5-49 NS
22/15 — NS
20 7.5-30 .0001
5.0 4.0-5.0 .0001
30 25.7-39 NS
4.0 3.0-4.0 NS
2.0 1.0-3.0 .0001
1.0 1.0-1.0 NS
1.0 1.0-1.0 NS
2 — .01
0 0-2.0 NScom
 14
52
96
8.0
45
4.0
4.0
1.0
1.0
3.0score.
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cations occurred after either open or laparoscopic proce-
dures. A regular diet was always resumed after an Rx
esophagogram performed on the fifth postoperative day
confirmed the absence of leaks at the myotomy site.
Subjective Outcome Assessment
Median follow-up was 85 months and ranged from 26 to
139 months. Both dysphagia and regurgitation scores as-
sessed at 24 months decreased significantly from 4 to 1,
with no intergroup difference in absolute change (Figure 1).
In both patients having chest pain preoperatively, the symp-
tom resolved soon after the operation. Heartburn disap-
peared postoperatively in the patient who had this symptom
before the procedure, whereas in 2 patients heartburn ap-
peared after the procedure. In both of these patients, esopha-
goscopy and 24-hour pH monitoring confirmed the presence
of esophagitis, which was satisfactorily treated with proton-
pump inhibitors.
Objective Outcome Assessment
All 6 patients who had lost some weight before the opera-
tion returned at least to their ideal body weight 12 months
after the operation. Esophageal width decreased by 10 mm
or more in 10 patients, by 20 to 30 mm in 6 patients, and by
more than 30 mm in one patient. The decrement in esoph-
ageal width was statistically significant in both groups, with
no intergroup difference (Figure 2, left panel). In patients
with sigmoid esophagus, the esophageal width decrease was
inversely correlated with age, so that the younger the age,
the greater the postoperative decrease in esophageal width
(Figure 3). In contrast, no correlation was found between
preoperative esophageal width and postoperative resizing of
the esophagus (R  0.08; P  not significant). Repeated
postoperative Rx esophagograms were performed in all
patients every 12 months and for at least 2 years, and 9
Figure 1. Postoperative change in subjective symptoms score.
Data are expressed as medians with interquartile ranges.patients underwent yearly esophagograms for more than 3
404 The Journal of Thoracic and Cardiovascular Surgery ● Septyears. Comparison of repeated esophagograms showed that
maximal esophageal width reduced significantly since the
12th postoperative month and remained stable subse-
quently, whereas the esophageal length did not change
(Figure 4).
Preoperative and postoperative manometry was per-
formed in 13 patients. LESP decreased significantly from 39
to 18 mm Hg (P  .001). Comparison with the results
achieved in 28 patients of the control group who underwent
preoperative and postoperative manometry showed no dif-
ference in change in LESP (Figure 2, right panel). Postop-
eratively, 3 patients had an LESP of greater than the upper
normal value of 20 mm Hg, with a median value of 25 mm
Hg. All these patients had residual mild dysphagia, and 2
underwent periodic pneumatic dilatation with satisfactory
results. Postoperative LESP was inversely correlated with
changes in dysphagia score (R  0.77; P  .001) and
changes in regurgitation score (R0.57; P .04), so that
the lower the LESP, the greater the change in symptom
score.
Esophagoscopy with multiple biopsies of the esophageal
mucosa was carried out in 8 patients after a mean of 26
months, showing grade 1 esophagitis in 2 patients and mild
squamous dysplasia in 1 patient. Continuous 24-hour pH
monitoring confirmed pathologic gastroesophageal acid re-
flux in both the patients with clinical and endoscopic evi-
dence of esophagitis, with a proportion of time at pH of less
than 4 of 19% and 22%, respectively.
QOL Assessment
Baseline SF-36 QOL domains scores in the sigmoid esoph-
agus and control group are reported in Table 2. The social
function and mental health domain scores were significantly
lower in the sigmoid esophagus group than in the control
group. At postoperative assessment, general health, social
function, and mental health domains improved significantly
(Table 3). The postoperative dysphagia score was inversely
correlated with preoperative to postoperative changes in
role physical (R  0.61; P  .04) and mental health (R 
0.68; P .02) domains, whereas postoperative LESP was
inversely correlated with changes in role physical (R 
0.72; P .01), role emotional (R0.62; P .03), and
mental health (R  0.72; P  .01). Comparison with the
control group results showed that absolute incremental
change in social function and mental health were greater in
patients with sigmoid esophagus, whereas no difference
existed between the groups in the remaining domains.
Up to the most recent follow-up, the procedure result was
scored as excellent in 6 (43%) patients, good in 4 (29%)
patients, and satisfactory or unsatisfactory in 2 patients
each. No patient required esophagectomy or had esophageal
carcinoma.
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The main finding of this study was that Heller myotomy
provided excellent to satisfactory symptom relief in 12 of 14
patients with achalasic sigmoid esophagus. It is also worth
noting that these subjective improvements were accompa-
nied by long-lasting improvements in end-expiratory resting
LESP, maximal esophageal width, and QOL SF-36 domain
scores, which did not differ from those achieved in a control
group of patients with earlier-stage achalasia. These results
corroborate and extend previous findings suggesting that
esophageal myotomy can improve symptoms even in pa-
tients with decompensated sigmoid esophagus.11,13,18
Although in no instance have we found restoration of
propulsive peristalsis in the sigmoid group, our findings
suggest that esophageal tone can be partially restored even
in these patients provided that adequate esophageal empty-
ing is ensured. This effect can be maximized in young
patients, who achieved the greatest reduction in esophageal
width and the best clinical results.
In agreement with previous study results,7,19 we have
found that postoperative LESP returned to within the nor-
mal range in 10 patients and that LESP changes correlated
with changes in dysphagia and regurgitation scores.
A further issue relates to whether a sigmoid-shaped
esophagus indicates a more advanced stage of disease. We
have found that symptom duration was significantly longer
in patients with sigmoid esophagus than in the control
group. Yet in this patient group we observed a greater
regurgitation score and more frequent respiratory symp-
toms. In accordance with our results, Shiino and col-
leagues20 have found that the maximal width of the esoph-
ageal body and tortuosity of the esophagus measured on
esophagography became greater with longer symptom du-
ration. Nonetheless, in our series the postoperative regurgi-
Figure 2. Postoperative change in objective measures
ranges.tation score decreased to the level of the control group, and
The Journal of Thoracino patient repeated respiratory symptoms postoperatively.
These results confirm the efficacy of the Heller myotomy
procedure in controlling these symptoms even in patients
with sigmoid esophagus. In addition, the operation was not
more technically demanding, had no more complications,
and resulted in just as good of relief of dysphagia as in
achalasic patients with an earlier stage of the disease.
The existence of symptoms leading to modification of
eating habits has been shown to impair QOL in achalasia,11
as well as in other benign esophageal diseases.21
The SF-36 questionnaire has proved a reliable instrument
10
Figure 3. Relationship between esophageal width and age in
patients with sigmoid esophagus.
re. Data are expressed as medians with interquartilescoto assess QOL after myotomy for achalasia. Ben Meir and
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vitality, and social function were significantly improved
after surgical intervention. Similarly, Luketich and cowork-
ers9 have found that after myotomy, all 8 domains of SF-36
data scored at least equal to or better than that of the normal
US population used for comparison.
Our findings support the use of the SF-36 as a reliable
instrument for preoperative and postoperative QOL assess-
ment in patients with achalasia. We have found that patients
with sigmoid esophagus had more severely impaired social
function and mental health domain scores than the control
group. On the other hand, in the sigmoid group greater
postoperative improvements occurred in these domains,
whereas improvements in role emotional and general health
domain scores compared with those of the control group.
We acknowledge some limitations of our study. First,
Figure 4. Preoperative (A) and postoperative (B) esop
reduction in esophageal width 12 months after Heller
TABLE 2. Baseline QOL assessment by using the SF-36 qu
SF-36
domain Sigmoid esophagus group (n  9)
PF 90 70-100
RP 55 25-75
BP 90 64-90
GH 60 55-75
SF 50 37-55
VT 60 45-65
RE 66 66-100
MH 64 56-68
Data are expressed as medians with interquartile ranges.
QOL, Quality of life; SF-36, Short-Form 36-item; PF, physical functioning; R
vitality; RE, role emotional; MH, mental health; NS, not significant.our series is not homogeneous in terms of surgical approach
406 The Journal of Thoracic and Cardiovascular Surgery ● Septbecause it included patients operated on by means of either
laparotomy or a laparoscopic approach. However, the tech-
nique was identical in all the patients, and all the procedures
were performed by the same surgeon. Moreover, there is
now sufficient evidence that long-term results of open ver-
sus laparoscopic Heller myotomy are comparable.2,3
Second, we had no control group treated with esopha-
gectomy, which constitutes the surgical alternative for these
patients. However, we believe that any attempt at preserving
the native esophagus should be made before deciding to
perform an esophagectomy for a benign disease. In fact,
despite the fact that esophageal substitution is now a safe
procedure that offers optimal clinical and functional out-
comes in the majority of the patients, it is more technically
demanding and carries a mortality rate of about 2%.14,22
In this study the Heller myotomy proved highly effective
grams of a 29-year-old patient showing a significant
omy.
nnaire
Control group (n  20)
Intergroup
P value
90 80-97.5 NS
75 65-75 NS
90 70-95 NS
60 55-83.5 NS
61 50-72.5 .02
55 45-60 NS
66 66-100 NS
72 66-76 .03
physical; BP, bodily pain; GH, general health; SF, social functioning; VT,hago
myotestio
P, rolein improving objective measures, subjective symptoms, and
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these improvements were long lasting and did not differ
from those achieved in a control group with earlier-stage
achalasia. Although confirmation by larger prospective
studies is warranted, the results achieved in this series lead
us to conclude that independent of the surgical approach,
Heller myotomy with anterior fundoplication should be
considered as a first-choice treatment option for achalasic
sigmoid esophagus.
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